JCI vs JNJ · P/E 44, rev $23.60B vs P/E 17, rev $49.37B
Johnson Controls International PLC (JCI) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
JCI currently screens at market cap $87.62B and trailing P/E 43.9. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the JCI and JNJ stock pages for the full models.
Not investment advice.